Evaxion Biotech A/S American Depositary Share is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer and infectious diseases. With a unique AI-driven platform, the company is positioned to revolutionize the field of precision medicine. Evaxion’s innovative approach has garnered significant attention from investors and industry experts, making it a promising player in the biotech sector.
